跳至主要内容
临床试验/CTRI/2016/08/007165
CTRI/2016/08/007165已完成4 期

A clinical study for the safety and effectiveness of Dual Chamber Rate Responsive Implantable Pacemaker model CHARAK 747R.

Shree Pacetronix Ltd0 个研究点目标入组 35 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • 1.Fixed (third degree) AV block
  • 2.Atrial Fibrillation with average Ventricular rate on ECG equal or less than than 40bpm or mean heart rate equal or less than 60bpm.
  • 3.Sinus node Dysfunction with PR interval equal or greater than 300msec
  • 4.Paroxysmal, persistent or permanent AF undergoing AV node , AV node/HIS ablation
  • 5.2°AV Block with equal or greater than 3:1 block
  • 6.The subject is 18 years of age or older
  • 7.The subject has provided written consent for the Pacemaker procedure.
  • 8.Pre-existing Cardiac Permanent pacemaker showing â??Beginning of Lifeâ??.

排除标准

  • 1.Pre-existing permanent cardiac pacemaker or ICD (defibrillator)
  • 2.Presence of Hypertrophic Obstructive Cardiomyopathy
  • 3.Recent cardiac surgery (equal or less than 30 days)
  • 4.Recent myocardial infarction (equal or less than 30 days)
  • 5.Presence of mechanical prosthetic tricuspid valve
  • 6.Current or planned pregnancy in the next 6 months.
  • 7.Patients with life expectancy less than 6 months.
  • 8.chronic renal failure

研究者

发起方
Shree Pacetronix Ltd

相似试验